The number of prescriptions for stimulants written for adults is increasing. Stimulant use disorder is also rising.

Among U.S. adolescents, current medical use of prescription stimulants for attention-deficit/hyperactivity disorder (ADHD) increased between 2005 and 2023, while nonmedical use decreased. Lifetime ...

Australia's pharmaceuticals watchdog is investigating a spike in adverse event reports for Vyvanse, the country's most ...

SaveHealth reports ADHD is a complex, lifelong condition affecting focus and impulse control, often needing a mix of ...

PDUFA Fee Waiver comes Days before Planned Submission of New Drug ApplicationKANSAS CITY, Kan., July 29, 2025 (GLOBE NEWSWIRE ...

A high dose of centanafadine was shown to be safe and effective at lowering ADHD symptoms for adolescents, according to ...

Current ADHD and autism screenings can take weeks and have monthslong wait times. With the AI-assisted test, it could take as ...

The FDA is revising the labeling of all extended-release ADHD medications to warn about adverse reactions in patients younger ...

Some people have to call around pharmacies to get their script filled, others change to different medications. And the ...

The mental health industry watchdog Citizens Commission on Human Rights International (CCHR) is calling for sweeping reforms ...

The FDA revises ADHD stimulant labels to warn of weight loss risk. Warnings target children under 6, noting higher adverse reaction rates. Stimulants, like Ritalin, increase dopamine and ...

Kids younger than 6 years on extended-release stimulants for ADHD may experience higher rates of side effects due to higher plasma exposures.